These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22261711)

  • 1. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
    Nezu T; Koga M; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Naganuma M; Minematsu K; Toyoda K
    Neurology; 2010 Aug; 75(6):555-61. PubMed ID: 20697108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
    Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K
    J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia.
    Nardi K; Engelter S; Strbian D; Sarikaya H; Arnold M; Casoni F; Ford GA; Cordonnier C; Lyrer P; Bordet R; Soinne L; Gensicke H; Duriez P; Baumgartner RW; Tatlisumak T; Leys D;
    Neurology; 2012 Sep; 79(11):1101-8. PubMed ID: 22843281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.
    Rocco A; Sykora M; Ringleb P; Diedler J
    Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
    Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
    Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
    Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
    Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
    Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Mori M; Nezu T; Makihara N; Koga M; Okada Y; Minematsu K; Toyoda K;
    Eur Neurol; 2011; 66(1):37-41. PubMed ID: 21709420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.